Predictmedix AI Inc. (PMEDF)
| Previous Close | 0.0316 |
| Open | 0.0314 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0313 - 0.0320 |
| 52 Week Range | 0.0220 - 0.1280 |
| Volume | |
| Avg. Volume | 18,076 |
| Market Cap | 4.204M |
| Beta (5Y Monthly) | 1.82 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREPredictmedix AI Achieves Significant Milestones in Mental Health Detection and Analysis
TORONTO, ON / ACCESSWIRE / December 5, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud ...
- ACCESSWIRE
Predictmedix AI Announces Successful Clinical Validation at the University of Raharja, Indonesia, Demonstrating 95% Accuracy in Vital Sign Detection
TORONTO, ON / ACCESSWIRE / November 14, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud ...
- ACCESSWIRE
Predictmedix AI Unveils Safe Entry Stations to Delegates from 30 Nations at D-30 Event in New Delhi
TORONTO, ON / ACCESSWIRE / November 6, 2023 / Predictmedix AI Inc. (CSE:PMED)(OTCQB:PMEDF)(FRA:3QP) (the "Company" or "Predictmedix"), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is proud ...
